Dementia and Geriatric Cognitive Disorders

Original Research Article

Anosognosia in Very Mild Alzheimer’s Disease but Not in Mild Cognitive Impairment

Kalbe E.a · Salmon E.b · Perani D.c · Holthoff V.d · Sorbi S.e · Elsner A.a · Weisenbach S.a · Brand M.f · Lenz O.a · Kessler J.a · Luedecke S.d · Ortelli P.c · Herholz K.a

Author affiliations

aDepartment of Neurology, University Hospital, and Max Planck Institute for Neurological Research, Cologne, Germany; bCyclotron Research Centre, University of Liège, Liège, Belgium; cVita Salute San Raffaele University, and Department of Neurology San Raffaele-Ville Turro, Milan, Italy; dDepartment of Psychiatry and Psychotherapy, Dresden University of Technology, Dresden, Germany; eDepartment of Neurological and Psychiatric Sciences, University of Florence, Florence, Italy; fDepartment of Physiological Psychology, University of Bielefeld, Bielefeld, Germany

Related Articles for ""

Dement Geriatr Cogn Disord 2005;19:349–356

Log in to MyKarger to check if you already have access to this content.


Buy

  • FullText & PDF
  • Unlimited re-access via MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!


If you would like to redeem your KAB credit, please log in.


Save over 20% compared to the individual article price.

Learn more

Rent/Cloud

  • Rent for 48h to view
  • Buy Cloud Access for unlimited viewing via different devices
  • Synchronizing in the ReadCube Cloud
  • Printing and saving restrictions apply

Rental: USD 8.50
Cloud: USD 20.00

Select

Subscribe

  • Access to all articles of the subscribed year(s) guaranteed for 5 years
  • Unlimited re-access via Subscriber Login or MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

Subcription rates


Select
* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

First-Page Preview
Abstract of Original Research Article

Received: September 09, 2004
Published online: April 29, 2005
Issue release date: May 2005

Number of Print Pages: 8
Number of Figures: 2
Number of Tables: 3

ISSN: 1420-8008 (Print)
eISSN: 1421-9824 (Online)

For additional information: https://www.karger.com/DEM

Abstract

Objective: To study awareness of cognitive dysfunction in patients with very mild Alzheimer’s disease (AD) and subjects with mild cognitive impairment (MCI). Methods: A complaint interview covering 13 cognitive domains was administered to 82 AD and 79 MCI patients and their caregivers. The patient groups were comparable according to age and education, and Mini Mental State Examination (MMSE) scores were ≧24 in all cases. The discrepancy between the patients’ and caregivers’ estimations of impairments was taken as a measure of anosognosia. Results: Self-reports of cognitive difficulties were comparable for AD and MCI patients. However, while in comparison to caregivers MCI patients reported significantly more cognitive impairment (p < 0.05), AD patients complained significantly less cognitive dysfunctions (p < 0.001). Conclusions: While most MCI patients tend to overestimate cognitive deficits when compared to their caregiver’s assessment, AD patients in early stages of disease underestimate cognitive dysfunctions. Anosognosia can thus be regarded as a characteristic symptom at a stage of very mild AD (MMSE ≧24) but not MCI. Accordingly, medical history even in mildly affected patients should always include information from both patient and caregiver.

© 2005 S. Karger AG, Basel




Related Articles:


References

  1. Agnew SK, Morris RG: The heterogeneity of anosognosia for memory impairment in Alzheimer’s disease: A review of the literature and a proposed model. Aging Ment Health 1998;2:7–19.
  2. Derouesné C, Thibault S, Lagha-Pierucci S, Baudouin-Madec V, Ancri D, Lacomblez L: Decreased awareness of cognitive deficits in patients with mild dementia of the Alzheimer type. Int J Geriatr Psychiatry 1999;14:1019–1030.
  3. Wagner MT, Spangenberg KB, Bachman DL, O’Connell P: Unawareness of cognitive deficit in Alzheimer disease and related dementias. Alzheimer Dis Assoc Disord 1997;11:125–131.
  4. Mullen R, Howard R, David A, Raymond L: Insight in Alzheimer’s disease. Int J Geriatr Psychiatry 1996;11:645–651.
    External Resources
  5. Migliorelli R, Teson A, Sabe L, Petracca G, Petracchi M, Leiguarda R, Starkstein SE: Anosognosia in Alzheimer’s disease: A study of associated factors. J Neuropsychiatry Clin Neurosci 1995;7:338–344.
  6. Koltai DC, Welsh-Bohmer KA, Schmechel DE: Influence of anosognosia on treatment outcome among dementia patients. Neuropsychol Rehabil 2001;11:455–475.
  7. Starkstein SE, Sabe L, Chemerinski E, Jason L, Leiguarda R: Two domains of anosognosia in Alzheimer’s disease. J Neurol Neurosurg Psychiatry 1996;61:485–490.
  8. Vasterling JJ, Seltzer B, Watrous WE: Longitudinal assessment of deficit unawareness in Alzheimer’s disease. Neuropsychiatry Neuropsychol Behav Neurol 1997;10:197–202.
  9. Kotler-Cope S, Camp CJ: Anosognosia in Alzheimer disease. Alzheimer Dis Assoc Disord 1995;9:52–56.
  10. Gil R, Arroyo-Anllo EM, Ingrand P, Gil M, Neau JP, Ornon C, Bonnaud V: Self-consciousness and Alzheimer’s disease. Acta Neurol Scand 2001;104:296–300.
  11. Sevush S, Leve N: Denial of memory deficit in Alzheimer’s disease. Am J Psychiatry 1993;150:748–751.
  12. Feher EP, Roderick K, Mahurin K, Inbody SB, Crook TH, Pirozzolo FJ: Anosognosia in Alzheimer’s disease. Neuropsychiatry Neuropsychol Behav Neurol 1991;4:136–146.
  13. Michon A, Deweer B, Pillon B, Agid Y, Dubois B: Relation of anosognosia to frontal lobe dysfunction in Alzheimer’s disease. J Neurol Neurosurg Psychiatry 1994;57:805–809.
  14. Lopez OL, Becker JT, Somsak D, Dew MA, DeKosky ST: Awareness of cognitive deficits and anosognosia in probable Alzheimer’s disease. Eur Neurol 1994;34:277–282.
  15. Ott BR, Lafleche G, Whelihan WM, Buongiorno GW, Albert MS, Fogel BS: Impaired awareness of deficits in Alzheimer disease. Alzheimer Dis Assoc Disord 1996;10:68–76.
  16. Harwood DG, Sultzer DL, Wheatley MV: Impaired insight in Alzheimer disease: Association with cognitive deficits, psychiatric symptoms, and behavioral disturbances. Neuro psychiatry Neuropsychol Behav Neurol 2000;13:83–88.
  17. Förstl H, Geiger-Kabisch C, Sattel H, Besthorn C, Schreiter-Gasser U, Abrahams CM, Biedert S: Self-rating and informant’s rating of clinical disorders in Alzheimer’s disease. Fortschr Neurol Psychiat 1996;64:228–233.
  18. Seltzer B, Vasterling JJ, Mathias CW, Brennan A: Clinical and neuropsychological correlates of impaired awareness of deficits in Alzheimer disease and Parkinson disease: A comparative study. Neuropsychiatry Neuropsychol Behav Neurol 2001;14:122–129.
  19. Sevush S: Relationship between denial of memory deficit and dementia severity in Alzheimer disease. Neuropsychiatry Neuropsychol Behav Neurol 1999;12:88–94.
  20. Zanetti O, Vallotti B, Frisoni GB, Geroldi C, Bianchetti A, Pasqualetti P, Trabucchi M: Insight in dementia: When does it occur? Evidence for a nonlinear relationship between insight and cognitive status. J Gerontol B Psychol Sci Soc Sci 1999;54:P100–P106.
  21. McDaniel KD, Edland SD, Heyman A, Investigators CC: Relationship between level of insight and severity of dementia in Alzheimer disease. Alzheimer Dis Assoc Disord 1995;9:101–104.
  22. Starkstein SE, Sabe L, Cuerva AG, Kuzis G, Leiguarda R: Anosognosia and procedural learning in Alzheimer’s disease. Neuropsychiatry Neuropsychol Behav Neurol 1997;10:96–101.
  23. Folstein MF, Folstein SE, McHugh PR: ‘Mini-mental state’. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189–198.
  24. Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL: A new clinical scale for the staging of dementia. Br J Psychiatry 1982;140:566–572.
  25. Petersen RC, Doody R, Kurz A, Mohs RC, Morris JC, Rabins PV, Ritchie K, Rossor M, Thal L, Winblad B: Current concepts in mild cognitive impairment. Arch Neurol 2001;58:1985–1992.
  26. Shah Y, Tangalos EG, Petersen RC: Mild cognitive impairment. When is it a precursor to Alzheimer’s disease? Geriatrics 2000;55:62, 65–68.
  27. Sramek JJ, Veroff AE, Cutler NR: The status of ongoing trials for mild cognitive impairment. Expert Opin Investig Drugs 2001;10:741–752.
  28. Larrieu S, Letenneur L, Orgogozo JM, Fabrigoule C, Amieva H, Le Carret N, Barberger-Gateau P, Dartigues JF: Incidence and outcome of mild cognitive impairment in a population-based prospective cohort. Neurology 2002;59:1594–1599.
  29. Tabert MH, Albert SM, Borukhova-Milov L, Camacho Y, Pelton G, Liu X, Stern Y, Devanand DP: Functional deficits in patients with mild cognitive impairment: Prediction of AD. Neurology 2002;58:758–764.
  30. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, ed 4. APA, 1994.
  31. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer’s disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology 1984;34:939–944.
  32. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E: Mild cognitive impairment: Clinical characterization and outcome. Arch Neurol 1999;56:303–308.
  33. Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J: The Neuropsychiatric Inventory: Comprehensive assessment of psychopathology in dementia. Neurology 1994;44:2308–2314.
  34. Delis DC, Kramer JH, Kaplan E, Ober BA: California Verbal Learning Test, Adult Version. San Antonio, The Psychological Corporation, 1987.
  35. Spreen O, Strauss E: A Compendium of Neuropsychological Tests: Administration, Norms, and Commentary. New York, Oxford University Press, 1998.
  36. Wechsler D: Wechsler Memory Scale, ed 3. San Antonio, The Psychological Corporation, 1997.
  37. Reitan R, Wolfson D: The Halstead-Reitan Neuropsychological Test Battery, Theory and clinical interpretation. Tucson, Neuropsychology Press, 1993.
  38. Huber W, Poeck K, Willmes K: The Aachen Aphasia Test. Adv Neurol 1984;42:291–303.
  39. Lawton MP, Brody EM: Assessment of older people: Self-maintaining and instrumental activities of daily living. Am J Psychiatry 1969;154:609–615.
  40. Hamilton M: Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 1967;6:278–296.
  41. Jorm AF, Christensen H, Korten AE, Henderson AS, Jacomb PA, Mackinnon A: Do cognitive complaints either predict future cognitive decline or reflect past cognitive decline? A longitudinal study of an elderly community sample. Psychol Med 1997;27:91–98.
  42. Carr DB, Gray S, Baty J, Morris JC: The value of informant versus individual’s complaints of memory impairment in early dementia. Neurology 2000;55:1724–1726.
  43. Albert SM, Michaels K, Padilla M, Pelton G, Bell K, Marder K, Stern Y, Devanand DP: Functional significance of mild cognitive impairment in elderly patients without a dementia diagnosis. Am J Geriatr Psychiatry 1999;7:213–220.
  44. Vogel A, Stokholm J, Gade A, Andersen BB, Heijl AM: Awareness of deficits in mild cognitive impairment and Alzheimer’s disease: Do MCI patients have impaired insight? Dement Geriatr Cogn Disord 2004;17:181–187.
  45. Zanetti O, Geroldi C, Frisoni GB, Bianchetti A, Trabucchi M: Contrasting results between caregiver’s report and direct assessment of activities of daily living in patients affected by mild and very mild dementia: The contribution of the caregiver’s personal characteristics. J Am Geriatr Soc 1999;47:196–202.
  46. Lamar M, Lasarev MR, Libon DJ: Determining levels of unawareness in dementia research. J Neuropsychiatry Clin Neurosci 2002;14:430–437.
  47. Tierney MC, Herrmann N, Geslani DM, Szalai JP: Contribution of informant and patient ratings to the accuracy of the Mini Mental State Examination in predicting probable Alzheimer’s disease. J Am Geriatr Soc 2003;51:813–818.

Article / Publication Details

First-Page Preview
Abstract of Original Research Article

Received: September 09, 2004
Published online: April 29, 2005
Issue release date: May 2005

Number of Print Pages: 8
Number of Figures: 2
Number of Tables: 3

ISSN: 1420-8008 (Print)
eISSN: 1421-9824 (Online)

For additional information: https://www.karger.com/DEM


Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
TOP